Suchergebnisse - "Amiot, Aurélien"

PubPharm (223)

21

Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Buisson, A. | Nachury, M. | Guilmoteau, T. | +9

CommentIn: Aliment Pharmacol Ther. 2023 Mar;57(6):733-734. - PMID 36821750

22

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Peyrin-Biroulet, L. | Rahier, J. | Kirchgesner, J. | +120

23

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease : a case-control study

enthalten in: Infection prevention in practice | 2023

von Amiot, A. | Bourrier, A. | Gornet, J. | +16

24

Long-Term Results of Endoscopic Metal Stenting for Biliary Anastomotic Stricture after Liver Transplantation

enthalten in: Journal of clinical medicine | 2023

von Becq, A. | Laurent, A. | De Roux, Q. | +12

25

The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

enthalten in: Journal of Crohn's & colitis | 2023

von Amiot, A. | Rahier, J. | Baert, F. | +110

ErratumIn: J Crohns Colitis. 2023 Jun 16;17(6):1025. - PMID 36808222

26

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

enthalten in: Frontiers in cardiovascular medicine | 2023

von Kharoubi, M. | Bézard, M. | Broussier, A. | +25

27

Editorial : ustekinumab during pregnancy - reassuring but still not enough

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Amiot, A. | Meyer, A. | Carbonnel, F.

CommentOn: Aliment Pharmacol Ther. 2022 Aug;56(3):477-490. - PMID 35560249

28

Editorial : ustekinumab during pregnancy ‐ reassuring but still not enough

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Amiot, A. | Meyer, A. | Carbonnel, F.

29

Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐ TNF agent

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Buisson, A. | Nachury, M. | Guilmoteau, T. | +9

30

Severe colitis in patients with melanoma treated with BRAF/ MEK inhibitors

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Carbonnel, F. | Routier, E. | Lazure, T. | +9